Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04130633 · ClinicalTrials.gov registry record · Phase 1

Behavioral Pharmacology of THC and Alpha-pinene

A Phase 1 study of THC and Alpha-pinene, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 1
Development phase
33
Enrollment target
1
Study location

NCT04130633 is a Phase 1 study of THC and Alpha-pinene that has completed, run by Johns Hopkins University. The registered enrollment target is 33 participants, below the 53-participant average among 9 other THC trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04130633, a Phase 1 study of THC and Alpha-pinene, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 1
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized alpha-pinene and THC administered via inhalation.

Conditions Studied

THC Alpha-pinene

Interventions

  • DRUG Placebo
  • DRUG THC
  • DRUG Alpha-Pinene

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2020-11-05
Est. Completion 2024-03-08
Phase Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04130633

The ClinicalTrials.gov registry entry for NCT04130633 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 53-participant average among 9 other THC trials with a reported enrollment target (38% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with THC appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT04130633 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04130633 about?

NCT04130633 is a clinical study titled "Behavioral Pharmacology of THC and Alpha-pinene". This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized alpha-pinene and THC administered via inhalation.

What is the current status of trial NCT04130633?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2020-11-05. Estimated completion is 2024-03-08.

What conditions does trial NCT04130633 study?

This clinical trial studies the following conditions: THC, Alpha-pinene.

What interventions are being tested in trial NCT04130633?

The interventions under investigation include: Placebo (DRUG), THC (DRUG), Alpha-Pinene (DRUG).

Who is sponsoring clinical trial NCT04130633?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04130633 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for THC

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

THC

All registered trials for this condition

Alpha-pinene

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.